// App-Quantinova.ai

2431 : Targeting of Casein Kinase II (CK2) Enhances Ikaros-Mediated Control of the Cell Cycle Progression in Pre-Clinical Model of Pre-B-ALL.

Researchers

Presenter

  • Chunhua Song

Principal Investigators

  • Kimberly J Payne

  • Chandrika S. Gowda

Medical Centers

  • Anatomy, Loma Linda University, Loma Linda, CA, USA,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Casein Kinase II

  • Cyclin dependent kinase 6

Drug/Treatment

  • Casein

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved